secwatch.observer — SEC 8-K summary
======================================

Issuer:     Replimune Group, Inc. (REPL)
CIK:        0001737953
Form:       8-K
Filed at:   2022-12-12T23:59:59+00:00
Accession:  0001104659-22-126323
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Replimune prices $225M public offering of common stock and pre-funded warrants
------------------------------------------------------------------------------

- Offering of 5.37M shares at $23.50/share and pre-funded warrants for 4.20M shares at $23.4999/warrant.
- Underwriters' 30-day option for 1.44M additional shares exercised in full.
- Net proceeds estimated at $242.6M after underwriting discounts and expenses.
- Offering expected to close December 13, 2022, funded from shelf registration.
- J.P. Morgan, SVB Securities, Piper Sandler, and BMO Capital Markets are joint book-runners.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1737953/000110465922126323/0001104659-22-126323-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1737953/000110465922126323/tm2232427d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-126323

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer